-
February 15, 2013
Shire's (SHPG) fourth quarter 2012 earnings (excluding special items) of $1.58 per American Depositary Share (ADS) ...
-
February 14, 2013
The HealthCare unit of Bayer AG (BAYRY) recently announced that the US Food and Drug Administration (FDA) granted ...
-
February 13, 2013
Bristol-Myers Squibb Company (BMY) recently announced that it has inked a deal with UK-based company Reckitt ...
-
February 13, 2013
Roche (RHHBY) recently entered into a drug discovery collaboration with privately-held RQx Pharmaceuticals, Inc. ...
-
February 13, 2013
AVEO Pharmaceuticals, Inc. (AVEO) and Astellas Pharma, Inc. (ALPMY) recently announced final overall survival (OS) ...
-
February 13, 2013
We are retaining our Neutral recommendation on global lab chemical and life sciences company Sigma-Aldrich ...
-
February 13, 2013
Shire plc (SHPG) recently settled its pending litigation with Impax Laboratories, Inc. (IPXL). The litigation is ...
-
February 12, 2013
Bayer (BAYRY) recently submitted applications to the US and the EU authorities for the approval of riociguat. Bayer ...
-
February 12, 2013
Teva Pharmaceutical Industries Ltd. (TEVA) recently announced that it has enrolled the first patient in the phase IV ...
-
February 12, 2013
Shire plc (SHPG) recently announced that the company has initiated a phase III study to evaluate the efficacy and ...
-
February 11, 2013
Acorda Therapeutics, Inc. (ACOR) recently announced that data from preclinical studies evaluating glial growth ...
-
February 11, 2013
Recently, GlaxoSmithKline (GSK) announced that it has submitted a regulatory application for its oncology candidate, ...
-
February 11, 2013
Novo Nordisk (NVO) recently faced a setback when the US Food and Drug Administration (FDA) declined to approve its ...
-
February 11, 2013
The Medicines Company (MDCO) recently announced that its two-year global collaboration agreement for Recothrom with ...
-
February 06, 2013
GlaxoSmithKline (GSK) recently increased its holding in its consumer healthcare subsidiary in India, GlaxoSmithKline ...
-
February 06, 2013
Bayer's (BAYRY) Healthcare unit and Johnson & Johnson's (JNJ) Janssen Pharmaceuticals recently collaborated with ...
-
February 05, 2013
Bayer AG (BAYRY) recently presented results from two European phase III studies on ATX-101. ATX-101 is being ...
-
February 05, 2013
Ireland-based Shire plc (SHPG) recently announced that the company has reached an agreement in principle to resolve ...
-
February 04, 2013
Recently, GlaxoSmithKline (GSK) announced the initiation of a phase III study (COMBI-AD) to evaluate its oncology ...
-
February 04, 2013
Teva Pharmaceutical Industries Ltd. (TEVA) recently terminated its collaboration with CureTech Ltd. for the ...
